Toripalimab
Coherus,Junshi Biosciences
['neotorch', 'toripalimab', 'nsclc', 'ts,perio,1', 'sclc', 'ts,perio,i']
neotorch by dr. shun lu. in stage iii nsclc, periop #toripalimab plus chemo improved over chemo alone efs (ne vs. 15.1 mo; hr=0.40), mpr 48.5 vs. 8.4%, pcr 24.8 vs. 1.0%. benefits seen across pd-l1 strata. another active peri-op regimen. mature os data awaited. #asco23 
Thoracic Medical Oncologist at Georgetown University | Father/husband/immigrant | #SoMeEditor @ClinicalLung | #LCSM